• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Infused Bone Marrow Fails to Prevent Vascularized Composite Allograft Rejection in Nonhuman Primates.

作者信息

Brazio P S, Woodall J, Panda A, Brown E N, Ha J S, Azimzadeh A M, Rodriguez E D, Bartlett S T, Bojovic B, Barth R N

机构信息

Department of Surgery, University of Maryland School of Medicine, Baltimore, MD.

Department of Plastic Surgery, Institute of Reconstructive Plastic Surgery, New York University Langone Medical Center, New York, NY.

出版信息

Am J Transplant. 2015 Jul;15(7):2011-2. doi: 10.1111/ajt.13268. Epub 2015 Apr 23.

DOI:10.1111/ajt.13268
PMID:25908397
Abstract
摘要

相似文献

1
Infused Bone Marrow Fails to Prevent Vascularized Composite Allograft Rejection in Nonhuman Primates.输注骨髓无法预防非人灵长类动物的血管化复合组织异体移植排斥反应。
Am J Transplant. 2015 Jul;15(7):2011-2. doi: 10.1111/ajt.13268. Epub 2015 Apr 23.
2
Prolonged survival of composite facial allografts in non-human primates associated with posttransplant lymphoproliferative disorder.复合面部同种异体移植在非人灵长类动物中长期存活与移植后淋巴细胞增生性疾病相关。
Transplantation. 2009 Dec 15;88(11):1242-50. doi: 10.1097/TP.0b013e3181c1b6d0.
3
Vascularized bone marrow-based immunosuppression inhibits rejection of vascularized composite allografts in nonhuman primates.血管化骨髓来源的免疫抑制抑制了非人灵长类动物血管化复合同种异体移植物的排斥反应。
Am J Transplant. 2011 Jul;11(7):1407-16. doi: 10.1111/j.1600-6143.2011.03551.x. Epub 2011 Jun 10.
4
Toward Development of the Delayed Tolerance Induction Protocol for Vascularized Composite Allografts in Nonhuman Primates.朝向建立非人类灵长类动物血管化复合异体移植物延迟耐受诱导方案。
Plast Reconstr Surg. 2020 Apr;145(4):757e-768e. doi: 10.1097/PRS.0000000000006676.
5
The Significance of Vascular Alterations in Acute and Chronic Rejection for Vascularized Composite Allotransplantation.血管改变在急性和慢性排斥反应中对血管化复合组织移植的意义。
J Vasc Res. 2019;56(4):163-180. doi: 10.1159/000500958. Epub 2019 Jul 2.
6
Facial and hand allotransplantation.面部和手部同种异体移植。
Cold Spring Harb Perspect Med. 2014 Mar 1;4(3):a015651. doi: 10.1101/cshperspect.a015651.
7
A novel rat full-thickness hemi-abdominal wall/hindlimb osteomyocutaneous combined flap: influence of allograft mass and vascularized bone marrow content on vascularized composite allograft survival.一种新型大鼠全层半腹壁/后肢骨肌皮联合皮瓣：同种异体移植物质量和带血管骨髓含量对血管化复合组织异体移植存活的影响。
Transpl Int. 2014 Sep;27(9):977-86. doi: 10.1111/tri.12364. Epub 2014 Jul 29.
8
Lymphocytic Vasculitis Associated With Mild Rejection in a Vascularized Composite Allograft Recipient: A Clinicopathological Study.血管化复合组织移植物受者伴轻度排斥反应的淋巴细胞性血管炎：临床病理研究。
Transplantation. 2020 Jul;104(7):e208-e213. doi: 10.1097/TP.0000000000003241.
9
Vascularized Composite Allotransplantation and Immunobiology: The Next Frontier.血管化复合组织异体移植与免疫生物学：新的前沿领域。
Plast Reconstr Surg. 2021 Jun 1;147(6):1092e-1093e. doi: 10.1097/PRS.0000000000007954.
10
Histopathology of chronic rejection in a nonhuman primate model of vascularized composite allotransplantation.血管化复合组织同种异体移植非人灵长类模型中慢性排斥反应的组织病理学。
Transplantation. 2013 May 27;95(10):1204-10. doi: 10.1097/TP.0b013e31828d1528.

引用本文的文献

1
Evaluating the immunogenicity of a mouse partial hindlimb for composite allotransplantation.评估小鼠部分后肢复合同种异体移植的免疫原性。
Front Immunol. 2025 Jun 18;16:1595319. doi: 10.3389/fimmu.2025.1595319. eCollection 2025.
2
Immunogenicity and tolerance induction in vascularized composite allotransplantation.血管化复合组织同种异体移植中的免疫原性与免疫耐受诱导
Front Transplant. 2024 Feb 13;3:1350546. doi: 10.3389/frtra.2024.1350546. eCollection 2024.
3
Challenges and opportunities in vascularized composite allotransplantation of joints: a systematic literature review.
关节移植的血管化复合组织异体移植的挑战和机遇：系统文献回顾。
Front Immunol. 2023 May 19;14:1179195. doi: 10.3389/fimmu.2023.1179195. eCollection 2023.
4
Clinical and preclinical tolerance protocols for vascularized composite allograft transplantation.血管化复合组织异体移植的临床和临床前耐受方案。
Arch Plast Surg. 2021 Nov;48(6):703-713. doi: 10.5999/aps.2021.00927. Epub 2021 Nov 15.
5
Large Animal Models of Vascularized Composite Allotransplantation: A Review of Immune Strategies to Improve Allograft Outcomes.大动物血管化复合组织同种异体移植模型：改善移植物结局的免疫策略综述。
Front Immunol. 2021 Jun 30;12:664577. doi: 10.3389/fimmu.2021.664577. eCollection 2021.
6
Vascularized Bone Marrow Cellular Depletion or Discontinuity Abrogates Protection of Vascularized Composite Allografts in Nonhuman Primates.血管化骨髓细胞耗竭或中断可消除非人灵长类动物中血管化复合组织异体移植的保护作用。
Transplant Direct. 2021 Jan 26;7(2):e659. doi: 10.1097/TXD.0000000000001107. eCollection 2021 Feb.
7
Preclinical Animal Models in Facial Transplantation.面部移植的临床前动物模型
Plast Reconstr Surg Glob Open. 2019 Sep 23;7(9):e2455. doi: 10.1097/GOX.0000000000002455. eCollection 2019 Sep.
8
The intragraft vascularized bone marrow component plays a critical role in tolerance induction after reconstructive transplantation.移植物内血管化骨髓成分在重建移植后诱导耐受中起着关键作用。
Cell Mol Immunol. 2021 Feb;18(2):363-373. doi: 10.1038/s41423-019-0325-y. Epub 2019 Nov 21.
9
Accommodation and related conditions in vascularized composite allografts.血管化复合组织异体移植中的适应性及相关情况。
Curr Opin Organ Transplant. 2017 Oct;22(5):470-476. doi: 10.1097/MOT.0000000000000446.